Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:32:41.420Z.
Calculation as of: 2026-10-06T16:32:41.420Z.
Quote observation: 2026-10-06T16:30:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 767633254d5919bd59cda52a5696942c7bb29bc9076435c5b91744fa0c767718
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$42.97M
EV/FCF Ratio
N/A
TTM Avg
16.14x
3Y Avg
18.58x
5Y Avg
128.19x
Market Cap
$47.83M
EV/FCF Ratio
N/A
TTM Avg
104.90x
3Y Avg
104.90x
5Y Avg
95.87x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.20M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $44.32M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.93M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $42.97M | N/A | 16.14x | 18.58x | 128.19x |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | N/A | 104.90x | 104.90x | 95.87x |
| Precipio, Inc. (PRPO)vs › | $42.63M | 54.36x | 75.69x | 62.69x | 62.69x |
| Lite Strategy, Inc. (LITS)vs › | $48.83M | N/A | N/A | N/A | N/A |
| Apollomics, Inc. (APLM)vs › | $49.89M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
